WebCytometix Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Pharmaceuticals Primary … WebDevelopment of Cytochrome P450 Therapy for Chronic Pain. Amount: $139,965.00. DESCRIPTION (provided by applicant): We have cloned and sequenced a novel cytochrome P450 (CYP) designated CYP4X1. The CYP4X1 mRNA and protein are highly expressed in neurons of the CNS and is ~80% h ... SBIR Phase I 2007 Department of …
Early stage drug developer Cytometix raises $1.9M in equity
WebMar 30, 2024 · CMXTwenty enters phase 2 on opioid alternative Rev Up. by Molly Dill March 18, 2024, 1:47 AM. CMXTwenty. Leadership: Lane Brostrom, CEO Headquarters: Wauwatosa What it Does: Developing opioid alternative drug Founded: 2008 (as Cytometix Inc.) Employees: Four Next goal: Complete phase 2 trials on CMX-020; Secure big … WebThis table reports the average proffered salary of labor condition applications for H-1B Visa and labor certifications for green card filed by Cytometix, Inc. from 2011 to 2024. If a range of proffered wage was used in application, we use the middle point in the range to calculate average salary. greenwood community center gym
BrightStar invests in two Milwaukee medical startups - BizTimes
WebCytometix. 9445 N Fairway Cir Milwaukee WI 53217 (414) 745-8000. Claim this business (414) 745-8000. Website. More. Directions Advertisement. Website Take me there. Find … WebWith ties to the Medical College of Wisconsin, Cytometix is a pharmaceutical development company that is developing CMX-020, a new molecular entity to treat pain. CMX-020 is similar in chemical structure to AM404, the active metabolite in acetaminophen. In animal studies, CMX-020 can be dose titrated to provide levels of analgesia equivalent ... WebSee Cytometix funding rounds, investors, investments, exits and more. Evaluate their financials based on Cytometix's post-money valuation and revenue. greenwood community centre